Serum Institute develops first indigenous vaccine against pneumonia; to be launched next week

India's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase 1, 2 and 3 clinical trial data submitted by the Pune-based firm.
Source: The Economic Times - Category: Consumer Health News Source Type: news